There is an error in the penultimate sentence of the "Detection of *bla* ~NDM-1~ positive isolates" subsection of the Results. The correct sentence is: These isolates were collected from 8 individual patients, consisting of 5 male (62.5%) and 3 female (37.5%) with a mean age of 29.7 years, including 2 infants (ECL-2, ECL-36).

There is an error in [Table 2](#pone.0140726.t001){ref-type="table"}, "Characteristics of *bla* ~NDM-1~-positive *E*. *cloacae*.*"* Please see the corrected [Table 2](#pone.0140726.t001){ref-type="table"} here.
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###### Characteristics of *bla* ~NDM-1~-positive *E*. *cloacae*.
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  Isolate      Clinical features   STs[^*a*^](#t001fn001){ref-type="table-fn"}   Associated resistance determinants[^*b*^](#t001fn002){ref-type="table-fn"}   Plasmid type carrying *bla* ~NDM-1~/ Plasmid size (kb)                                                                               
  ------------ ------------------- --------------------------------------------- ---------------------------------------------------------------------------- -------------------------------------------------------- ------- -------------------------------------- ------------- -------------- ----------------
  ECL-2        7m/female           sputum                                        Cardial Surgery                                                              discharge                                                ST177   [TEM-1]{.ul}、EBC、CMY-2、CTX-M-1      RmtB          \-             Untypeable/70
  ECL-4        48y/male            blood                                         ICU                                                                          discharge                                                ST88    [TEM-1]{.ul}、ACT-20、[CTX-M-3]{.ul}   \-            \-             N/65
  ECL-27       57y/male            blood                                         ICU                                                                          discharge                                                ST90    ACT-20、[CTX-M-G9]{.ul}                \-            \-             Untypeable/55
  ECL-36       15d/male            sputum                                        NICU                                                                         death                                                    ST41    MIR-2                                  \-            \-             A/C/160
  ECL-37       37y/male            urine                                         Urology                                                                      discharge                                                ST120   ACT-20、[CTX-M-3]{.ul}                 \-            \-             Untypeable/55
  ECL- 62      25y/female          urine                                         Neurosurgery                                                                 death                                                    ST120   [ACT-20]{.ul}、[CTX-M-15]{.ul}         [ArmA]{.ul}   [fosA3]{.ul}   HI2/340
  ECL- ZMD10   49y/male            wound                                         Burn unit                                                                    discharge                                                ST120   \-                                     [ArmA]{.ul}   [fosA3]{.ul}   Untypeable/360
  ECL- ZMD12   21y/female          blood                                         Hematology                                                                   death                                                    ST93    \-                                     [ArmA]{.ul}   \-             A/C/55

^*a*^ ST: Sequence type determined by multilocus sequence typing (MLST)

^*b*^ Resistance markers that are co-transferred with *bla* ~NDM-1~by conjugation are underlined. Minus signs indicate negative results.

There is an error in [Table 3](#pone.0140726.t002){ref-type="table"}, "Antibiotic susceptibilities of *bla* ~NDM-1~-positive *E*. *cloacae* and transconjugants (μg/mL)." Please see the corrected [Table 3](#pone.0140726.t002){ref-type="table"} here.
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###### Antibiotic susceptibilities of *bla* ~NDM-1~-positive *E*. *cloacae* and transconjugants (μg/mL).
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  Isolate no.[^*a*^](#t002fn001){ref-type="table-fn"}   Antibiotics [^*b*^](#t002fn002){ref-type="table-fn"}                                                                                                                                                             
  ----------------------------------------------------- ------------------------------------------------------ ----------- ----------- -------- -------- ---------- ---------- ----------- ----------- ----------- ----------- --------- ----------- ----------- ------- -------
  ECL-2                                                 \>256                                                  \>256       \>256       32       \>32     1          1          \>256       \>256       \>320       \>256       64        \>256       32          2       0.5
  ECL-4                                                 \>256                                                  \>256       \>256       64       \>32     16         \>32       8           16          \>320       \>256       32        128         64          16      0.5
  ECL-27                                                \>256                                                  \>256       \>256       \>64     \>32     \>32       16         64          2           \>320       \>256       64        \>256       16          3       1
  ECL-36                                                \>256                                                  \>256       \>256       32       \>32     \<0.25     \<0.25     32          \<2         \>320       256         8         4           8           2       1
  ECL-37                                                \>256                                                  \>256       \>256       16       32       16         \>32       \>256       \>256       \>320       \>256       32        128         64          3       1
  **ECL-62**                                            **\>256**                                              **\>256**   **\>256**   **64**   **32**   **16**     **32**     **\>256**   **\>256**   **\>320**   **\>256**   **256**   **\>256**   **\>512**   **4**   **1**
  **ECL-ZMD10**                                         **64**                                                 **\>256**   **\>256**   **8**    **32**   **\>32**   **\>32**   **\>256**   **\>256**   **\>320**   **256**     **256**   **256**     **128**     **1**   **1**
  **ECL-ZMD12**                                         **\>256**                                              **\>256**   **\>256**   **8**    **32**   **\>32**   **\>32**   **\>256**   **\>256**   **\>320**   **\>256**   **256**   **256**     **32**      **3**   **2**
  *E*. *coli* Transconjugant Strains                                                                                                                                                                                                                                     
  ECL-2-J53                                             \>256                                                  \>256       \>256       32       32       1          0.5        64          64          \>320       128         8         64          16          1       0.5
  ECL-4-J53                                             \>256                                                  \>256       \>256       32       32       16         32         2           8           \>320       128         8         32          16          4       0.5
  ECL-27-J53                                            \>256                                                  \>256       \>256       32       \>32     16         8          16          2           \>320       \>256       32        64          8           1.5     1
  ECL-36-J53                                            64                                                     \>256       \>256       32       \>32     \<0.25     \<0.25     32          \<2         \>320       \<1         8         8           8           1.5     1
  ECL-37-J53                                            \>256                                                  \>256       \>256       16       32       16         32         16          \>64        \>320       \>256       16        128         32          1.5     1
  ECL-62-J53                                            \>256                                                  \>256       \>256       32       16       16         32         64          \>64        \>320       \>256       32        128         \>512       2       1
  ECL-ZMD10-J53                                         64                                                     \>256       \>256       4        16       32         16         \>256       \>256       \>320       128         256       256         128         1.5     0.5
  ECL-ZMD12-J53                                         \>256                                                  \>256       \>256       8        32       32         32         \>256       16          \<20        \>256       256       256         32          3       1
  EC J53                                                \<4                                                    \<1         \<1         \<1      \<0.5    \<0.25     \<0.25     \<1         \<2         \<20        \<1         8         2           2           0.25    0.5

^*a*^ ECL, *E*. *cloacae* strains; For the transconjugants, all were *E*. *coli* J53 harboring plasmids from the respective clinical isolates. All of the *bla* ~NDM-1~-positive isolates were multidrug-resistant (MDR) strains, the XDR isolates are highlighted in bold type.

^*b*^ Abbreviations used:TZP, piperacillin/tazobactam (0.5/4-256/4); CAZ, ceftazidime (0.03--256); FEP, cefepime (0.015--256); IPM, imipenem(0.06--64); ETP, ertapenem(0.004--32); CIP, ciprofloxacin (0.004--32); LEV, levofloxacin (0.008--32); GEN, gentamicin (0.25--256); AMK, amikacin (0.5--256); ATM, aztreonam (0.06--256); CHL, chloroamphenicol (0.016--256); TET, tetracycline (0.016--256); FOS, fosfomycin (0.25--512); TGC, tigecycline (0.016--256); CST, colistin (0.016--256). The numbers in parentheses indicate the test range (μg/mL) for each agent.
